Pratyasha Ghosh1 and Mrinal K Ghosh2*
1CGHS, Kolkata, India
2Signal Transduction in Cancer and Stem Cells Laboratory, Division of Cancer Biology and
Inflammatory Disorder, Council of Scientific and Industrial Research-Indian Institute of
Chemical Biology (CSIR-IICB), Kolkata, India
*Corresponding Author: Mrinal K Ghosh, Signal Transduction in Cancer and Stem Cells Laboratory, Division of Cancer Biology and Inflammatory Disorder, Council of Scientific and Industrial Research-Indian Institute of Chemical Biology (CSIR-IICB), Kolkata, India.
Received: March 31, 2020; Published: May 13, 2020
Outbreak of COVID-19 is caused by the novel coronavirus designated as 2019-nCoV or SARS-CoV-2. This super-spreader has proven to be devastating for health care systems. The trajectory of this outbreak is impossible to predict in any nation so far; effective response requires prompt action from the public and private health strategies for immediate development and implementation of effective treatment to counterattack the infective 2019-nCoV particles.
Citation: Pratyasha Ghosh and Mrinal K Ghosh. “2019-nCoV: Strategy to Combat the Ongoing Outbreak and Future Perspectives”.Acta Scientific Cancer Biology 4.6 (2020): 07-08.
Copyright: © 2020 Pratyasha Ghosh and Mrinal K Ghosh. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Open Access by
Acta Scientific is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at https://actascientific.com
ff
